BACKGROUND/OBJECTIVES: It is estimated that zinc deficiency affects 17% of the world's population, and because of periods of rapid growth children are at an increased risk of deficiency, which may lead to stunting. This paper presents a systematic review and meta-analysis of the randomised controlled trials (RCTs) that assess zinc intake and growth in children aged 1-8 years. This review is part of a larger systematic review by the European Micronutrient Recommendations Aligned Network of Excellence that aims to harmonise the approach to setting micronutrient requirements for optimal health in European populations (www.eurreca.org). SUBJECT/METHODS: Searches were performed of literature published up to and including December 2013 using MEDLINE, Embase and the Cochrane Library databases. Included studies were RCTs in apparently healthy child populations aged from 1 to 8 years that supplied zinc supplements either as capsules or as part of a fortified meal. Pooled meta-analyses were performed when appropriate. RESULTS: Nine studies met the inclusion criteria. We found no significant effect of zinc supplementation of between 2 weeks and 12 months duration on weight gain, height for age, weight for age, length for age, weight for height (WHZ) or WHZ scores in children aged 1-8 years. CONCLUSIONS: Many of the children in the included studies were already stunted and may have been suffering from multiple micronutrient deficiencies, and therefore zinc supplementation alone may have only a limited effect on growth.
INTRODUCTION
Suboptimal dietary zinc intake is increasingly recognised as an important public health issue. It is estimated that the risk of low dietary intake of absorbable zinc and consequent zinc deficiency affects 17% of the world's population. 1 Factors that contribute to zinc deficiency include consumption of high phytate-containing cereal and low protein intake, commonly found in the diets of non-industrialised populations, which impairs zinc absorption. 2, 3 Zinc deficiency is particularly prevalent in South and Southeast Asia, Latin America and sub-Saharan Africa. 2, 4, 5 Frequent clinical infections such as diarrhoea, also common in non-industrialised regions, also affect zinc absorption. 6, 7 Children are particularly vulnerable to zinc deficiency due to an increased requirement during periods of rapid growth. 6 Zinc deficiency may impair growth and contribute to stunting in children. 3, 8, 9 One suggested mechanism is altered growth hormone metabolism. 10 It has been estimated that 171 million children (167 million in developing countries) are stunted and 20% of children under 5 years in low-and middle-income countries have a weight for age (WAZ) score (WAZ Z-score) of o− 2. 5 Although severe zinc deficiency is uncommon in European populations, marginal deficiency is likely to be much more prevalent. 11 Although the global prevalence of childhood stunting has decreased in the past decade (from 39.7% in 1990 to 26.7% in 2010), stunting remains a major public health problem. 12 Several systematic reviews have explored the relationship between preventive zinc supplementation and growth in children, but have reported discordant findings. [13] [14] [15] [16] A high degree of heterogeneity was observed in many of the meta-analyses performed, owing in part to inclusion of data from children with a wide age range in pooled analyses. Brown et al. 13 pooled data from infants and pre-pubertal children; Ramakrishnan et al. 15 and Imdad et al. 16 pooled data from infants and children under 5 years of age and Brown et al.
14 included infants, children and adolescents in their meta-analyses. Such wide-ranging ages incorporate several periods where growth is particularly rapid (during infancy and puberty for example) and during which the child's nutrient needs correspond with these changes in growth rates. Growth in the first year of life is particularly rapid, with more than a doubling of birth weight and a 50% increase in body length. 17 The velocity of statural growth, which may reach as much as 30 cm/year in the first 2 months of life, decreases to a third of this rate by 10 months and continues to decline sharply until 2-3 years of age. 18 After 2 years of age, rates of weight gain and statural growth show a slow, downward trend and reach a nadir just before the beginning of the pubertal growth spurt, sometime between ages 9 and 15 years. 19 To minimise the confounding influence of combining disparate age groups, we conducted a systematic review and meta-analysis of all available randomised controlled trials (RCTs), meeting the European Micronutrient Recommendations Aligned (EURRECA) inclusion 1 criteria, which investigated the relationship between zinc intake and growth (height, weight gain, growth Z-scores) in children aged 1-8 years.
MATERIALS AND METHODS

Search strategy
This research was conducted within the framework of the EURRECA Network of Excellence, which aims to harmonise the approach to setting the micronutrient requirements for optimal health in European populations (www.eurreca.org). This review was part of a wider review process to identify studies assessing the effect of zinc intake on different outcomes (biomarkers of zinc status and health outcomes). The wider searches were performed in literature published up to and including February 2010 using MEDLINE, Embase and Cochrane, using search terms for ['study designs in humans'] AND [zinc] AND [intake OR status]. An updated search was conducted in December 2013. Both indexing and text terms were used. The full Ovid MEDLINE search strategy can be found as Supplementary information available at EJCN's website. Reference lists of retrieved articles and published literature reviews were also checked for relevant studies. Authors were contacted to request missing data or to clarify methods or results. The search process is illustrated in Figure 1 .
Inclusion/exclusion criteria Included studies were RCTs in apparently healthy child populations aged from 1 to 8 years that supplied supplemental zinc as an oral dose or as part of a fortified meal. If supplemental zinc was provided as a component of a fortified meal, studies were only included if zinc was the only constituent that was different between treatment groups. Only studies that reported sufficient data or had sufficient data obtainable from the authors to estimateβ and s.e.(β) for the assumed linear relation on the log elog e scale were included. Studies were excluded if they included infants aged o12 months or pubertal children aged ⩾ 9 years, if they were conducted in animals or if they were group RCTs (community trials), case studies, uncontrolled trials, commentaries, reviews or duplicate publications from the same study. Group RCTs were excluded from all reviews conducted by the EURRECA consortium due to the increased risk of confounding factors, such as the outbreak of disease, food shortage or differing school hours specific to each localised group, influencing specific outcomes of interest. Studies were excluded if children were hospitalised, had severe protein-energy malnutrition or a chronic disease or if supplemental zinc was provided for o2 weeks. Only studies available in languages (English, Dutch, French, German, Hungarian, Italian, Norwegian, Polish, Spanish, Greek and Serbian) spoken by the EURRECA Network were included.
Selection of articles
Of 9653 identified articles in the wider 2010 and updated 2013 search on zinc intake, status and priority health outcomes in all populations, 5042 were excluded based upon screening of the title and abstract. Two independent reviewers screened 10% of the abstracts in duplicate, and any discrepancies were discussed before screening the remaining references. Following subdivision into appropriate population groups, the full texts of the 340 manuscripts were assessed to determine inclusion and exclusion by two independent reviewers, and disagreements were rectified Figure 1 . Study selection process.
through discussion. In all, 292 studies were excluded because they did not meet the inclusion criteria. Of the remaining 48 studies, 29 studies were excluded because they had not investigated the relationship between zinc intake and childhood growth, but related either intake to status directly and were reported elsewhere 20 or to a health end point other than growth. Six papers identified as reporting zinc intake and growth data were omitted from the review because there was lack of sufficient data on growth to calculate effect size, such as reporting growth velocity with no baseline data, or not providing the standard deviation or means to calculate the s.d. A further four studies were omitted from the meta-analysis because they included children older than 8 years or younger than 12 months, despite the reported mean falling into the eligible age range. For the purpose of this review, nine RCTs met our inclusion criteria. As one paper 21 assessed three zinc doses in separate groups of participants, eleven estimates of zinc intake and child growth were eligible for meta-analysis.
Data extraction
For each of the identified manuscripts, data were extracted into a standardised database. All data extracted from the papers were checked in duplicate. Extracted data included population characteristics, dose of zinc in intervention and placebo supplements, duration of the study, dietary intake of zinc, weight, height for age (HAZ), WAZ, length for age (LAZ), weight for height (WHZ) and weight for length (WLZ).
Data synthesis
If a change in weight or z-score was reported, as well as the baseline data, the final value was calculated. If dietary intake of zinc (in addition to the intervention) was not reported, we used a value of 5.65 mg/day; this was the mean dietary intake level of the RCTs (n = 8) that did report dietary zinc intake. In instances in which a factorial design was used, only data in which zinc was the only difference could be used. In the meta-analyses, one study that included three zinc-treated groups and one control group was treated as three independent estimates. 21 Four studies reported growth data at more than one time point, and the growth data at the final time point were used for two of the studies; 22, 23 for the other two studies, the growth data from the 6-month and 3-month time point, respectively, were used, as this was the closest measurement after the supplementation period ceased. 24, 25 Statistical analyses Pooled meta-analyses were performed by combining the evidence from the nine RCTs identified in the search. The transformations used to derive coherent single-study estimates from the available summary statistics per study have been described elsewhere. 26 In short, we estimated an intake-growth regression coefficient (β) for each individual study, on the basis of the assumption of a linear relation on the log e -log e -scale (natural logarithm of intake versus natural logarithm of status). Algebraically deriving an estimate from each study of the regression coefficient (β) and its standard error (s.e.(β)) enabled us to compare the results from studies with heterogeneously reported associations and effects. We calculated the overall pooledβ and SE(β) using random-effects meta-analysis, which estimates the between-study variance using the method of DerSimonian and Laird and used this estimate to modify the weights used to calculate the summary estimate. Residual heterogeneity between studies was evaluated using the I 2 statistic. Meta-analyses were run for six measures of growth: weight, HAZ, LAZ, WAZ, WHZ and WLZ. The statistical transformations to obtain β's and SE(β)'s were performed using GenStat version 13-SP2 (VSN International Ltd, http://www.vsni.co.uk/), and the meta-analysis was performed using STATA version 11.0 (College Station, TX, USA), with statistical significance defined as P o0.05.
Assessment of risk of bias in included studies
To assess the quality of the study and the risk of bias, indicators of internal validity were collected during data extraction. On the basis of the indicators, two independent reviewers assessed the overall risk of bias, and each study was classified as low, moderate or high risk. The criteria for judging these indicators were adapted from the Cochrane Handbook. 27 
RESULTS
Eleven estimates of zinc intake and child growth in nine RCTs were eligible for meta-analysis (Table 1 ). All studies were RCTs published between 1983 and 2008, which reported zinc intake and a growth outcome. The eleven estimates included a total of 1316 participants with sample sizes ranging from 20 to 165. One study was conducted in Africa, five in Central and South America, two in North America and one in the Indian Sub-continent. All of the studies in this meta-analysis had low initial mean HAZ scores, below or approaching o− 2.0 with varying levels of stunting reported. Gibson et al. 22 included only male children, and the remaining studies provided combined data on both boys and girls. Zinc was provided as zinc sulphate, [21] [22] [23] [24] [25] 28 ,29 zinc methionine 30 or amino acid chelate as a chewable supplement, 31 dissolved in a flavoured solution, 30 fresh fruit juice 22, 23 or as a syrup. 21, 24, 25, 28, 29 Only two studies reported that they attempted to administer the zinc under fasting condition. 21, 29 The duration of the studies ranged from 2 to 12 months, and the supplementation periods ranged from 14 days to 12 months. Supplement doses ranged from 3 to 20 mg Zn/day (median 10 mg), and the doses were provided daily in most studies. 21, 22, 24, 25, 28, 29 Some studies, however, provided zinc supplements several times per week, 23, 30, 31 resulting in daily dose equivalents ranging from 7.14 to 14.29 mg zinc/day. Weight Weight was assessed in three studies. 21, 23, 31 Although weight gain was observed to occur in all included studies in both zincsupplemented and placebo groups, no significant differences between the zinc-supplemented and placebo groups at the end of the study were reported (Table 1) . Consequently, no significant pooled effect of zinc supplementation was found for weight change (pooled beta-coefficient of 0.01; 95% CI − 0.01, 0.02; Figure 2 ). The studies in this meta-analysis were homogeneous (I 2 0.0%, P = 0.852).
HAZ Score
None of the seven studies that reported HAZ scores [22] [23] [24] [28] [29] [30] [31] found a significant difference between the zinc-supplemented and placebo groups at the end of the study, and a pooled analysis found no significant association between zinc supplementation and change in HAZ score (pooled beta-coefficient 0.04; 95% CI − 0.13, 0.22; Figure 3 ). The studies in this meta-analysis were homogeneous (I 2 48.6%, P = 0.070).
WAZ Score Eight studies reported WAZ scores. [21] [22] [23] [24] [25] 28, 30, 31 None of these studies reported a significant difference in WAZ score between the zinc-supplemented and placebo groups at the end of the study. Rahman et al. 25 reported WAZ score gains in both the zincsupplemented and placebo groups, but the difference between the two groups was not significantly different. Our pooled analysis revealed no statistically significant association between zinc supplementation and change in WAZ score in children aged Figure 4 ). The studies in this meta-analysis were highly homogeneous (I 2 0.0%, P = 0.586).
LAZ Score
Only two studies investigated the relationship between LAZ and zinc supplementation, and neither found a significant difference between zinc-supplemented and placebo groups at the end of the study, although both reported an increased LAZ in both zincsupplemented and placebo groups over the duration of the studies. 21, 25 Our pooled analysis confirmed that zinc supplementation was not significantly associated with a change in LAZ score in children aged between 1 and 8 years (pooled beta-coefficient − 0.001; 95% CI − 0.11, 0.10; Figure not shown). The studies in this meta-analysis were homogeneous (I 2 0.0%, P = 0.780).
WLZ Score
Two studies investigated the relationship between WLZ and zinc supplementation, and neither found a significant difference in WLZ score between the zinc-supplemented and placebo groups at the end of the study. 21, 25 Wuehler et al. 21 reported an improved WLZ score over time in both zinc-supplemented and placebo groups, whereas Rahman et al. 25 reported a decline in WLZ scores over time in both zinc-supplemented and placebo groups. A pooled analysis confirmed that zinc supplementation was not significantly associated with a change in WLZ score (pooled betacoefficient 0.05; 95% CI: − 0.04, 0.14; Figure not shown). The studies in this meta-analysis were homogeneous (I 2 0.0%, P = 0.612).
WHZ Score
Four studies investigated WHZ score in children 22, [28] [29] [30] but none found a significant difference in WHZ score between the zincsupplemented and placebo groups at the end of the study. A pooled analysis confirmed that zinc supplementation was not significantly associated with a change in WHZ score in this population (pooled beta-coefficient 0.02; 95% CI − 0.11, 0.16; Figure 5 ). The studies in this meta-analysis were homogeneous (I 2 0.0%, P = 0.705).
Risk of bias
The risk of bias was low for the studies by Rahman et al. 25 and Wuehler et al., 21 moderate for the studies by Walravens et al., 28 Sempertegui et al. 24 and Kikafunda et al. 23 and high for the remaining four studies (Supplementary information is available at EJCN's website). 22, [29] [30] [31] Papers were given a high risk of bias rating owing to reasons such as insufficient information provided on sequence generation and/or allocation, study blinding, drop-outs and funding bodies.
DISCUSSION
This systematic review was undertaken to investigate the association between zinc intake and indices of growth in children aged between 1 and 8 years. Eleven estimates in nine RCTs, which enrolled a total of 1316 children, were included in seven metaanalyses. In pooled analyses, no statistically significant effects of zinc supplementation were found on weight, HAZ, WAZ, LAZ, WHZ and WLZ scores in children of this age group. A major strength of the current review is the meta-analysis of statistically homogeneous studies. Although previous meta-analyses found statistically significant effect sizes on various aspects of child growth, all have suffered from high heterogeneity.
Four systematic reviews have been published that have investigated the relationship between zinc supplementation and growth in children, but there is considerable variability in their review inclusion criteria, making it difficult to provide firm conclusions about the nature of this relationship. [13] [14] [15] [16] In contrast to our study, the two systematic reviews by Brown et al. 13, 14 reported statistically significant positive effects of zinc supplementation on linear growth and weight gain. A marginally statistically significant effect of zinc on change in WHZ was reported by Brown et al.
14 , but not in their earlier study. 13 Imdad et al. 16 also reported a significant positive effect of zinc supplementation on linear growth. Statistically significant heterogeneity was found among the studies included in linear growth and weight-gain meta-analyses in all three reviews, likely to be due in part to the inclusion of data from infants, children and/or adolescents. In addition, Brown et al. 13 included hospitalised, severely malnourished children in their 2002 meta-analyses, although they excluded such children in their subsequent review. 14 Our findings confirm those of Ramakrishnan et al. 15 who found no significant effect of zinc supplementation on height or weight gain in 43 studies of children under 5 years of age. They did, however, report a small positive effect (effect size = 0.06; 95% CI: 0.006, 0.11) on change in WHZ. This review differs from that of ours in that more than half of their included studies were conducted in infants (initial age o12 months) and some studies included small-for-gestational age infants.
Our review has combined homogeneous studies to provide an accurate estimate of the influence of zinc supplementation on measures of growth in children. We achieved high homogeneity in our meta-analyses by restricting the age group. We also excluded studies that have been included in previous reviews that involved anaemic or malnourished children, children who were of low birth weight or small-for-gestational age children, as well as community trials.
Although all studies included in our meta-analyses were undertaken in individuals without chronic disease or severe protein-energy malnutrition, other factors such as infection and inflammation may also have gone unreported. For example, only one study screened and excluded participants with parasitic infection; 29 other studies treated pre-existing micronutrient deficiencies by supplementing the children with multivitamin and/or mineral supplements during the baseline 31 or prebaseline 21 period. Other limitations include the absence of large well-designed trials, lack of studies that attempt to administer zinc under fasting conditions to avoid the influence of dietary factors such as phytate on zinc bioavailability and the lack of data provided on baseline nutritional status, which make it difficult to identify the conditions under which these interventions may be beneficial. The nonsignificant effect of supplemental zinc on childhood growth identified in this meta-analysis, however, cannot be explained by an ineffective absorption of zinc from a supplement per se, because the fractional absorption of zinc from supplements is comparable to that of a phytate-free meal. 32, 33 
CONCLUSIONS
The methods used to conduct this review were thorough and robust, allowing only the most rigorous and well-designed studies to be included, while reducing the impact that confounding factors may have. The resulting meta-analyses suggested no statistically significant improvement of several indices of childhood growth following zinc supplementation in children aged 1-8 years of age. As most of the studies included in the review involved children who were stunted, it is likely that multiple micronutrient deficiencies exist, which is why zinc alone did not significantly improve growth. Positive effect Effect size Figure 5 . Random-effects meta-analyses of RCTs evaluating the effect of dietary zinc on WHZ score in children aged 1-8 years. Beta's represent the regression coefficients for the linear association between log-transformed zinc intake and WHZ score.
